Dejan Micic to Antirheumatic Agents
This is a "connection" page, showing publications Dejan Micic has written about Antirheumatic Agents.
Connection Strength
0.328
-
Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis. Ann Rheum Dis. 2021 03; 80(3):384-391.
Score: 0.185
-
Efficacy, safety and pharmacokinetics of biosimilars of anti-tumor necrosis factor-a agents in rheumatic diseases; A systematic review and meta-analysis. J Autoimmun. 2017 May; 79:4-16.
Score: 0.143